Thai Hospital Stocks Slump as 30-Baht Scheme Expands, Analysts Warn

Maybank Securities (Thailand) has trimmed its sector weighting on Thai hospital stocks, a decision that may curb fresh capital flows for private healthcare providers and reshape investment opportunities for locals and expats.

Key Takeaways

• Minimal institutional allocations – most funds now treat hospital shares as a tertiary position.

• 3% cap on revenue growth – private hospital top lines stagnated despite rising medical costs.

• Valuations near 17× earnings for 2026 – a steep discount to Singapore and Malaysia peers.

• Patient migration to public facilities highlights an affordability squeeze under the 30-baht universal care scheme.

The Funding Landscape Shift

Analysts at Maybank Securities (Thailand) note that major pension and mutual funds in Singapore and Kuala Lumpur have scaled back exposure to hospital equities, leaving many portfolios with under 5% allocation. This pullback stems from a lack of domestic catalysts and muted earnings growth, which has relegated healthcare stocks to non-core status on the Thailand Stock Exchange. Without significant inflows, share prices have corrected to levels that already embed much of the downside risks identified by the brokerage.

Pricing Pressures and Patient Migration

An enduring affordability wall is driving cost-sensitive Thais toward public wards, where the 30-baht universal care model and SSO coverage cap out-of-pocket expenses. According to the Thailand Ministry of Public Health, outpatient volumes at state facilities rose by 6% in 2024, forcing private chains to limit price hikes and absorb cost inflation beyond 10%. This trend erodes private hospitals' pricing power, compresses margins, and triggers slower revenue growth — capped at around 3% in the latest fiscal cycle.

Earnings Visibility vs Growth Capex

Among listed operators, Bangkok Dusit Medical Services (BDMS) stands out for its diverse hospital network and robust earnings visibility, earning the top recommendation from Maybank Securities (Thailand). In contrast, Bangkok Chain Hospital (BCH) offers a cheaper entry point but faces elevated capital spending on new facilities, which could dilute returns in the near term. Investors must weigh BDMS's stability against BCH’s expansion risks in a low-growth environment.

What This Means for Residents

For everyday Thai families and long-stay expats, the shift in hospital financing translates to more bargaining power at public clinics and a need to shop around for private care. Under the 30-baht scheme, routine check-ups at state clinics now take an average of 50 minutes, down from two hours last year, according to a survey by the National Health Security Office. Meanwhile, the Thailand Ministry of Public Health has expanded telemedicine subsidies, cutting a follow-up consultation from ฿1,200 to under ฿300. Households should also review their SSO entitlements, as higher wage ceilings for contributions may cover more advanced procedures at no extra cost.

Impact on Expats & Investors

Valuations on the Thailand Stock Exchange have reset to roughly 17× forecast earnings for fiscal 2026 — about 40% below Singapore’s average. That makes hospital shares an intriguing option for yield-seeking expats. BDMS offers around 1.7% dividend yield, while BCH and PR9 hover near 2.5%. Still, foreigners should note baht volatility, which swung between ฿34 and ฿36 per USD this year, and keep an eye on co-payment policy shifts set for late March, which could alter private revenue streams.

Longer-Term Outlook

Looking past 2026, Thailand is on pace to become super-aged by 2030, with one in five citizens over 60, according to the Thailand National Economic and Social Development Council. This demographic shift will sustain demand for chronic-care and wellness services, even as the government experiments with bundled payments and premium clinics in state hospitals. Select operators with strong regional partnerships and digital platforms stand to benefit from a more integrated healthcare ecosystem.